Verastem (VSTM) PT Raised to $19 at RBC Capital
very_bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
very_bullish
What happened, with direct paths to the underlying reporting
RBC Capital raises VSTM target to $19; current price $7.71; implied upside ~146%.
Target: $19
Posted price: $7.71
Analyst firm: RBC Capital
Analyst: Leonid Timashev
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.